Treatment of recurrent penile condylomata acuminata with external application and intraurethral instillation of bacillus Calmette-Guerin

Journal of Urology

Volumn 160, Issue 2, 1998, Pages 394-396

  Bohle, A ^a   Doehn, C ^a   Kausch, I ^a   Jocham, D ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

BCG vaccine; Condylomata acuminata; Penis

Indexed keywords

BCG VACCINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONDYLOMA ACUMINATUM; DYSURIA; HUMAN; IMMUNOTHERAPY; INTRAURETHRAL DRUG ADMINISTRATION; LASER SURGERY; MALE; PRIORITY JOURNAL; RECURRENCE RISK; RELAPSE; TOPICAL DRUG ADMINISTRATION; WART VIRUS;

EID: 0345493200     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)62906-9     Document Type: Article

References (28)

1. Syrjänen, K. J.: HPV in genital squamous cell tumors: epidemiology and clinical synopsis. In: Genital Papillomavirus Infections. Edited by G. Gross, S. Jablonska, H. Pfister and H. E. Stegner. New York: Springer-Verlag, pp. 3-12, 1990.
2. Bonnez, W., Oakes, D., Bailey-Farchione, A., Choi, A., Hallahan, D., Pappas, P., Holloway, M., Corey, L., Barnum, G., Dunne, A., Stoler, M. H., Demeter, L. M. and Reichman, R. C.: A randomized, double-blind, placebo-controlled trial of systemically administered interferon-alpha, -beta, or -gamma in combination with cryotherapy for the treatment of condyloma acuminata. J. Infect. Dis., 171: 1081, 1995.
3. Grin, W.: Condyloma acuminata-Epidemiologie und Therapie. Wien. Klin. Wochenschr., 104: 215, 1992.
4. Barrasso, R., De Brux, J., Croissant, O. and Orth, G.: High prevalence of papillomavirus-associated penile intraepithelial neoplasia in sexual partners of women with cervical intraepithelial neoplasia. New Engl. J. Med., 317: 916, 1987.
5. von Knebel Doeberitz, M. and zur Hausen, H.: Biological significance of human papillomavirus early gene expression in human cervical carcinoma cells. In: Genital Papillomavirus Infections. Edited by G. Gross, S. Jablonska, H. Pfister and H. E. Stegner. New York: Springer-Verlag, pp. 51-65, 1990.
6. Smith, K. T. and Campo, M. S.: Papillomaviruses and their involvement in oncogenesis. Biomed. Pharmacother., 39: 405, 1985.
7. Pfister, H.: Biology and biochemistry of papillomaviruses. Rev. Physiol. Biochem. Pharmacol, 99: 111, 1984.
8. Syrjänen, S. M., von Krogh, G. and Syrjänen, K. J.: Detection of human papillomavirus DNA in anogenital condylomata in men using in situ DNA hybridisation applied to paraffin sections. Genitourin. Med., 63: 32, 1987.
9. Wiener, J. S., Effert, P. J., Humphrey, P. A., Yu, L., Liu, E. T. and Walter, P. J.: Prevalence of human papilloma virus types 16 and 18 in squamous-cell carcinoma of the penis: a retrospective analysis of primary and metastatic sections by differential polymerase chain reaction. Int. J. Cancer, 50: 694, 1992.
10. Ferenczy, A., Mitao, M., Nagai, N., Silverstein, S. J. and Crum, C. P.: Latent papillomavirus and recurring genital warts. New Engl. J. Med., 313: 784, 1985.
11. Swinehart, J. M., Sperling, M., Phillips, S., Kraus, S., Gordon, S., McCarty, J. M., Webster, G. F., Skinner, R., Korey, A. and Orenberg, E. K.: Intralesional fluorouracil/epinephrine injectable gel for treatment of condylomata acuminata. A phase 3 clinical study. Arch. Dermatol., 133: 67, 1997.
12. von Krogh, G., Szpak, E., Andersson, M. and Bergelin, I.: Self-treatment using 0.25%-0.50% podophyllotoxin-ethanol solutions against penile condylomata acuminata: a placebo-controlled comparative study. Genitourin. Med., 70: 105, 1994.
13. Syed, T. A. and Lundin, S.: Topical treatment of penile condylomata acuminata with podophyllotoxin 0.3% solution, 0.3% cream and 0.15% cream. A comparative open study. Dermatology, 187: 30, 1993.
14. Davis, B. E. and Noble, M. J.: Initial experience with combined interferon-α 2B and carbon dioxide laser for the treatment of condylomata acuminata. J. Urol., 147: 627, 1992.
15. Gross, G., Roussaki, A., Baur, S., Wiegand, M. and Mescheder, A.: Systemically administered interferon alfa-2a prevents recurrence of condylomata acuminata following CO2-laser ablation. The influence of the cyclic low-dose therapy regimen. Results of a multicentre double-blind placebo-controlled clinical trial (Letter to the Editor). Genitourin. Med., 72: 71, 1996.
16. Monsonego, J., Cessot, G., Ince, S. E., Galazka, A. R. and Abdul-Ahad, A. K.: Randomised double-blind trial of recombinant interferon-beta for condyloma acuminatum. Genitourin. Med., 72: 111, 1996.
17. Cardamakis, E., Kotoulas, I.-G., Metalinos, K., Mantouvalos, H., Relakis, K., Scrapari, M., Korantzis, A. and Papathanasiou, Z.: Treatment of urethral condylomata acuminata or flat condylomata with interferon-α2a. J. Urol., 152: 2011, 1994.
18. Cardamakis, E. K., Kotoulas, I.-G., Dimopoulos, D. P., Stathopoulos, E. N., Michopoulos, J. T. and Tzingounis, V. A.: Comparative study of systemic interferon alfa-2a with oral isotretionin and oral isotretionin alone in the treatment of recurrent condylomata acuminata. Arch. Gynec. Obst., 258: 35, 1996.
19. Tsambaos, D., Georgiou, S., Monastirli, A., Sakkis, T. H., Sagriotis, A. and Goerz, G.: Treatment of condylomata acuminata with oral isotretionin. J. Urol., 158: 1810, 1997.
20. Guidotti, L. G. and Chisari, F. V.: To kill or to cure: options in host defense against viral infection. Curr. Opin. Immunol., 8: 478, 1996.
21. Kershaw, M. H., Trapani, J. A. and Smyth, M. J.: Cytotoxic lymphocytes: redirecting the cell-mediated immune response for the therapy of cancer. Ther. Immunol., 2: 173, 1995.
22. Baniel, J., Lev, Z., Engelstein, D. and Servadio, C.: Penile edema and meatal ulceration after intravesical instillation with bacillus Calmette-Guerin. Urology, 47: 932, 1996.
23. Ratliff, T. L., Ritchey, J. K., Yuan, J. J. J., Andriole, G. L. and Catalona, W. J.: T-cell subsets required for intravesical BCG immunotherapy for bladder cancer. J. Urol., 150: 1018, 1993.
24. Böhle, A., Gerdes, J., Ulmer, A. J., Hofstetter, A. G. and Flad, H. D.: Effects of local bacillus Calmette-Guerin therapy in patients with bladder carcinoma on immunocompetent cells of the bladder wall. J. Urol., 144: 53, 1990.
25. Coleman, N., Birley, H. D., Renton, A. M., Hanna, N. F., Ryait, B. K., Byrne, M., Taylor-Robinson, D. and Stanley, M. A.: Immunological events in regressing genital warts. Amer. J. Clin. Path., 102: 768, 1994.
26. Böhle, A., Nowc, C., Ulmer, A. J., Musehold, J., Gerdes, J., Hofstetter, A. G. and Flad, H. D.: Elevations of cytokines interleukin-1, interleukin-2 and tumor necrosis factor in the urine of patients after intravesical bacillus Calmette-Guerin immunotherapy. J. Urol., 144: 59, 1990.
27. Wu, R., Coleman, N. and Stanley, M.: Different susceptibility of cervical keratinocytes containing human papillomavirus to cell-mediated cytotoxicity. Chin. Med. J. Engl., 109: 854, 1996.
28. Kyo, S., Inoue, M., Hayasaka, N., Inoue, T., Yutsudo, M., Tanizawa, O. and Hakura, A.: Regulation of early gene expression of human papillomavirus type 16 by inflammatory cytokines. Virology, 200: 130, 1994.